Quotes Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
20:08:07 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 243.15 EUR | +0.93% |
|
+2.76% | +43.09% |
Stock exchange
Deutsche Boerse AG
RV6 245.90 €
+2.08%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| CRL | 281.90USD | -1.65% | 89.42M $ | ||
CBOE
| CRL | 282.44USD | -1.46% | 3.16M $ | |
Tradegate
| RV6 | 245.60EUR | -0.81% | 11.3K € | |
Mexican S.E.
| CRL * | 4,720.00MXN | -1.97% | 61.36K $ | |
Deutsche Boerse AG
| RV6 | 245.90EUR | +2.08% | 0 € | |
Börse Stuttgart
| RV6 | 243.30EUR | +1.63% | 0 € | |
Boerse Muenchen
| RV6 | 244.70EUR | -1.03% | 0 € | |
Berne S.E.
| RV6 | 231.61CHF | +2.93% | 0 CHF |
Quotes 5-day view: Charles River Laboratories International, Inc.
Delayed Quote Deutsche Boerse AG| 12/08/2026 | 13/08/2026 | 14/08/2026 | 17/08/2026 | 18/08/2026 | |
|---|---|---|---|---|---|
| Last | €243.60 | €246.10 | €244.60 | €240.90 | €245.90 |
| Volume | 9 | 0 | 45 | 0 | 0 |
| Change | +1.80% | +1.03% | -0.61% | -1.51% | +0.93% |
| Opening | €242.30 | €246.10 | €243.00 | €240.90 | €245.90 |
| High | €243.60 | €246.10 | €244.60 | €240.90 | €245.90 |
| Low | €242.30 | €246.10 | €243.00 | €240.90 | €245.90 |
Performance
| 1 day | +1.10% | ||
| 1 week | +2.76% | ||
| Current month | +20.48% | ||
| 1 month | +25.81% | ||
| 3 months | +91.29% | ||
| 6 months | +83.99% | ||
| Current year | +43.09% | ||
| 1 year | +84.19% | ||
| 3 years | +34.56% | ||
| 5 years | -30.93% | ||
| 10 years | +236.58% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
13,683,870,270
Market Cap (USD)
13,683,870,270
Net sales (USD)
4,015,382,000
Number of employees
19,000
Sales / Employee (USD)
211,336
Free-Float
95.58 %
Free-Float capitalization (EUR)
15,721,519,011
Free-Float capitalization (USD)
13,578,675,970
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
242.9
Moving average 20 days
212.76
Moving average 50 days
194.02
Moving average 100 days
171.03
Price spread / (MMA5)
-0.27%
Price spread / (MMA20)
-12.64%
Price spread / (MMA50)
-20.34%
Price spread / (MMA100)
-29.78%
RSI 9 days
82.27
RSI 14 days
78.82
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.10% | +2.76% | +84.19% | +34.56% | 13.68B | ||
| -0.11% | -1.67% | +1.80% | +19.90% | 48.84B | ||
| +1.03% | +3.97% | +486.31% | +621.51% | 45.44B | ||
| +1.56% | +2.19% | +14.97% | +90.17% | 41.22B | ||
| +0.46% | -0.67% | +25.80% | +13.19% | 39.71B | ||
| -2.74% | -2.74% | +17.30% | +56.10% | 32.6B | ||
| +2.00% | -0.92% | - | - | 16.25B | ||
| -1.16% | -2.68% | +27.29% | +136.00% | 16.67B | ||
| -0.49% | -0.34% | +3.45% | +29.14% | 14.08B | ||
| -1.66% | -0.09% | +79.48% | +41.66% | 13.68B | ||
| Average | +0.01% | -0.78% | +82.29% | +115.80% | 28.22B | |
| Weighted average by Cap. | +0.13% | -0.84% | +102.04% | +146.67% |
Historical Quotes: Charles River Laboratories International, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 240.9 | 246.1 | |
| 1 month | 191.45 | 246.1 | |
| Current year | 127.95 | 246.1 | |
| 1 year | 124.25 | 246.1 | |
| 3 years | 87.7 | 251.8 | |
| 5 years | 87.7 | 388 | |
| 10 years | 59.83 | 388 |
Monthly variations
Annual variations
| 2026 | +40.18% | ||
| 2025 | -3.32% | ||
| 2024 | -16.98% | ||
| 2023 | +3.16% | ||
| 2022 | -36.72% | ||
| 2021 | +62.38% | ||
| 2020 | +47.45% | ||
| 2019 | +44.38% | ||
| 2018 | +4.91% | ||
| 2017 | +26.84% | ||
| 2016 | -1.68% | ||
| 2015 | +38.94% | ||
| 2014 | +36.70% | ||
| 2013 | +38.74% | ||
| 2012 | +33.11% | ||
| 2011 | -22.60% | ||
| 2010 | +16.20% | ||
| 2009 | +29.89% | ||
| 2008 | -60.35% | ||
| 2007 | +37.10% | ||
| 2006 | -8.80% | ||
| 2005 | +6.03% | ||
| 2004 | +22.44% | ||
| 2003 | -24.97% | ||
| 2002 | -3.81% | ||
| 2001 | +30.48% | ||
| 2000 | +8.35% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Quotes Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions

















